HDIM
CLB icon

Hanson & Doremus Investment Management’s Core Laboratories CLB Stock Holding History

Hanson & Doremus Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,148
Closed -$15K – 530
2022
Q3 		$15K Hold
1,148
– – ﹤0.01% 400
2022
Q2 		$23K Hold
1,148
– – 0.01% 370
2022
Q1 		$36K Hold
1,148
– – 0.01% 341
2021
Q4 		$26K Hold
1,148
– – 0.01% 362
2021
Q3 		$32K Hold
1,148
– – 0.01% 325
2021
Q2 		$18K Hold
1,148
– – 0.01% 323
2021
Q1 		$33K Hold
1,148
– – 0.01% 322
2020
Q4 		$30K Hold
1,148
– – 0.01% 313
2020
Q3 		$18K Buy
+1,148
New +$24.1K 0.01% 323

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Hanson & Doremus Investment Management's CLB Position: Q4 2022 in Review

Hanson & Doremus Investment Management sold out of Core Laboratories (CLB) in Q4 2022, closing a stake of 1,148 shares — an estimated $15K sold.

Hanson & Doremus Investment Management first reported a position in CLB in Q3 2020 and held it in 9 quarters. The position peaked at $36K in Q1 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q4 2022.

  • Hanson & Doremus Investment Management reported no remaining Core Laboratories position as of Q4 2022 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 1,148 Core Laboratories shares in Q4 2022, an estimated $15K.
  • Hanson & Doremus Investment Management first reported a position in Core Laboratories in Q3 2020 and held it in 9 quarters.
  • Hanson & Doremus Investment Management's Core Laboratories position peaked at $36K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2022.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2022, filed 18 Jan 2023.